# Case Study: Resurrecting the Guardian of the Genome

**Target**: Oncology Biotech | **Subject**: P53 Tumor Suppressor

## The Challenge

P53 is the most frequent mutation in human cancer. "Resurrecting" its function in tumors is the Holy Grail of oncology. The challenge is structural stability: most mutations that restore DNA binding also destabilize the protein, causing it to unfold and degrade.

## The Solution

We used **Ternary VAE v5.11** to generate a library of 10,000 synthetic P53 variants.
Unlike structure-based methods (AlphaFold) that simulate folding physics, our model learned the **evolutionary rules of stability** from 500 million years of vertebrate evolution.

## The Result

- **Design T-729**: A variant with 14 mutations compared to wild-type.
- **Thermostability**: +5°C melting point vs human P53.
- **Binding Affinity**: Retained 95% of DNA binding capability.
- **Immunogenicity**: Predicted "Silent" (low MHC-II presentation).

## Business Impact

- **Drug Candidate**: A stable, super-charged P53 for mRNA delivery or gene therapy.
- **Platform Validation**: Proves the engine can design _functional_ human proteins, not just viral antigens.

## Why We Won

The **3-Adic Quantization** allowed the model to treat amino acid substitutions not as continuous vectors (like ESM-1v), but as discrete choices in a decision tree. This prevented the "blurry" predictions common in continuous VAEs, where the model outputs an "average" amino acid that doesn't physically exist.
